GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Premier Biomedical Inc (OTCPK:BIEI) » Definitions » Operating Margin %

Premier Biomedical (Premier Biomedical) Operating Margin % : -10,700.00% (As of Dec. 2019)


View and export this data going back to 2012. Start your Free Trial

What is Premier Biomedical Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Premier Biomedical's Operating Income for the three months ended in Dec. 2019 was $-0.11 Mil. Premier Biomedical's Revenue for the three months ended in Dec. 2019 was $0.00 Mil. Therefore, Premier Biomedical's Operating Margin % for the quarter that ended in Dec. 2019 was -10,700.00%.

The historical rank and industry rank for Premier Biomedical's Operating Margin % or its related term are showing as below:


BIEI's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.355
* Ranked among companies with meaningful Operating Margin % only.

Premier Biomedical's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Premier Biomedical's Operating Income for the three months ended in Dec. 2019 was $-0.11 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2019 was $-0.33 Mil.


Premier Biomedical Operating Margin % Historical Data

The historical data trend for Premier Biomedical's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Premier Biomedical Operating Margin % Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Operating Margin %
Get a 7-Day Free Trial Premium Member Only - - -3,225.00 -1,795.00 -2,335.71

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,422.22 -1,366.67 -1,825.00 -2,166.67 -10,700.00

Competitive Comparison of Premier Biomedical's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Premier Biomedical's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Premier Biomedical's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Premier Biomedical's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's Operating Margin % falls into.



Premier Biomedical Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Premier Biomedical's Operating Margin % for the fiscal year that ended in Dec. 2019 is calculated as

Operating Margin %=Operating Income (A: Dec. 2019 ) / Revenue (A: Dec. 2019 )
=-0.327 / 0.014
=-2,335.71 %

Premier Biomedical's Operating Margin % for the quarter that ended in Dec. 2019 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2019 ) / Revenue (Q: Dec. 2019 )
=-0.107 / 0.001
=-10,700.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Premier Biomedical  (OTCPK:BIEI) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Premier Biomedical Operating Margin % Related Terms

Thank you for viewing the detailed overview of Premier Biomedical's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Premier Biomedical (Premier Biomedical) Business Description

Traded in Other Exchanges
N/A
Address
2409 Sycamore Drive, Knoxville, TN, USA, 37921
Premier Biomedical Inc is engaged in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.

Premier Biomedical (Premier Biomedical) Headlines

From GuruFocus

Premier Biomedical, Inc. CEO Letter - April 2018

By ACCESSWIRE AccessWire 04-12-2019

Premier Biomedical, Inc. CEO Letter - October, 2018

By ACCESSWIRE AccessWire 04-12-2019

PainReliefMeds.com Resumes Credit Card Processing

By ACCESSWIRE AccessWire 04-12-2019